Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
8500
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Report on the exercise status of Series 3 and Series 4 stock acquisition rights with provisions for exercise price adjustments and suspension designation
発行・処分する株式数
Shares delivered during the month: 8,500 shares (8,500 new shares and 0 transferred treasury shares)
発行済株式総数
0.35% (8,500 shares delivered during the month across all series / 2,447,320 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Series 3 stock acquisition rights: exercise prices during the month were ¥2,521, ¥2,534, ¥2,543, ¥2,546, ¥2,547, ¥2,544, ¥2,553 and ¥2,535. Details of the adjustment provisions and floor price: Not disclosed. Series 4 stock acquisition rights: exercise price: Not disclosed.
Number of Stock Acquisition Rights
Series 3: 1,650 rights issued in total (85 exercised; 1,195 unexercised at the end of the month). Series 4: Not disclosed.
Procedures under the Corporate Code of Conduct
Report on compliance with exercise restrictions under the Tokyo Stock Exchange's Securities Listing Regulations, Article 434, and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters.
Most recent equity financing
6 July 2026: Issuance of Series 3 and Series 4 stock acquisition rights (issue price and amount: Not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the exercise status of Series 3 and Series 4 stock acquisition rights with provisions for exercise price adjustments and suspension designation |
| Number of shares to be issued or disposed of | Shares delivered during the month: 8,500 shares (8,500 new shares and 0 transferred treasury shares) |
| Dilution Rate | 0.35% (8,500 shares delivered during the month across all series / 2,447,320 listed shares as of the payment date for the issuance) |
| Total number of issued shares | As of the end of the preceding month: 2,484,320 shares (including 248 treasury shares) → Not disclosed |
| Exercise price | Series 3 stock acquisition rights: exercise prices during the month were ¥2,521, ¥2,534, ¥2,543, ¥2,546, ¥2,547, ¥2,544, ¥2,553 and ¥2,535. Details of the adjustment provisions and floor price: Not disclosed. Series 4 stock acquisition rights: exercise price: Not disclosed. |
| Number of Stock Acquisition Rights | Series 3: 1,650 rights issued in total (85 exercised; 1,195 unexercised at the end of the month). Series 4: Not disclosed. |
| Procedures under the Corporate Code of Conduct | Report on compliance with exercise restrictions under the Tokyo Stock Exchange's Securities Listing Regulations, Article 434, and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters. |
| Most recent equity financing | 6 July 2026: Issuance of Series 3 and Series 4 stock acquisition rights (issue price and amount: Not disclosed) |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the stock acquisition rights.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.